Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Procaps Group (PROCW) Competitors

PROCW vs. AIMDW, ALVOW, ARAV, ACABW, and RNA

Should you be buying Procaps Group stock or one of its competitors? The main competitors of Procaps Group include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry.

How does Procaps Group compare to Ainos?

Procaps Group (NASDAQ:PROCW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, earnings and media sentiment.

In the previous week, Procaps Group's average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company Overall Sentiment
Procaps Group Neutral
Ainos Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Procaps Group$414.10MN/AN/AN/AN/A
Ainos$124.16KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Procaps GroupN/A N/A N/A
Ainos N/A N/A N/A

Summary

Procaps Group beats Ainos on 1 of the 1 factors compared between the two stocks.

How does Procaps Group compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Procaps Group (NASDAQ:PROCW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$586.32MN/AN/AN/AN/A
Procaps Group$414.10MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Procaps Group N/A N/A N/A

In the previous week, Alvotech's average media sentiment score of 0.00 equaled Procaps Group'saverage media sentiment score.

Company Overall Sentiment
Alvotech Neutral
Procaps Group Neutral

Summary

Alvotech beats Procaps Group on 1 of the 1 factors compared between the two stocks.

How does Procaps Group compare to Aravive?

Aravive (NASDAQ:ARAV) and Procaps Group (NASDAQ:PROCW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
Procaps Group$414.10MN/AN/AN/AN/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
Procaps Group N/A N/A N/A

In the previous week, Aravive's average media sentiment score of 0.00 equaled Procaps Group'saverage media sentiment score.

Company Overall Sentiment
Aravive Neutral
Procaps Group Neutral

Summary

Aravive beats Procaps Group on 2 of the 3 factors compared between the two stocks.

How does Procaps Group compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Procaps Group (NASDAQ:PROCW) are both pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
Procaps Group$414.10MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
Procaps Group N/A N/A N/A

In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Procaps Group'saverage media sentiment score.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Procaps Group Neutral

Summary

Procaps Group beats Atlantic Coastal Acquisition Corp. II on 1 of the 1 factors compared between the two stocks.

How does Procaps Group compare to Avidity Biosciences?

Avidity Biosciences (NASDAQ:RNA) and Procaps Group (NASDAQ:PROCW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

Procaps Group has higher revenue and earnings than Avidity Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avidity Biosciences$18.62MN/A-$322.30MN/AN/A
Procaps Group$414.10MN/AN/AN/AN/A

Avidity Biosciences presently has a consensus target price of $69.42, suggesting a potential upside of 437.73%. Given Avidity Biosciences' stronger consensus rating and higher probable upside, research analysts plainly believe Avidity Biosciences is more favorable than Procaps Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avidity Biosciences
1 Sell rating(s)
12 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.32
Procaps Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Procaps Group has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. Procaps Group's return on equity of 0.00% beat Avidity Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Avidity Biosciences-3,650.39% -44.92% -39.57%
Procaps Group N/A N/A N/A

In the previous week, Avidity Biosciences had 1 more articles in the media than Procaps Group. MarketBeat recorded 1 mentions for Avidity Biosciences and 0 mentions for Procaps Group. Avidity Biosciences' average media sentiment score of 0.00 equaled Procaps Group'saverage media sentiment score.

Company Overall Sentiment
Avidity Biosciences Neutral
Procaps Group Neutral

Summary

Avidity Biosciences beats Procaps Group on 5 of the 9 factors compared between the two stocks.

Get Procaps Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PROCW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PROCW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PROCW vs. The Competition

MetricProcaps GroupDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$1.62B$6.25B$11.77B
Dividend YieldN/A2.97%2.74%5.26%
P/E RatioN/A4.1829.2527.07
Price / SalesN/A1,488.53504.6873.47
Price / CashN/A10.3743.3053.90
Price / BookN/A10.729.676.69
Net IncomeN/A$21.15B$3.55B$332.64M

Procaps Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PROCW
Procaps Group
N/A$0.02
flat
N/AN/A$0.00$414.10MN/A4,900
AIMDW
Ainos
N/A$0.05
-35.8%
N/AN/A$0.00$124.16KN/A40
ALVOW
Alvotech
N/A$0.26
+21.3%
N/AN/A$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat
N/AN/A$0.00N/AN/A15

Related Companies and Tools


This page (NASDAQ:PROCW) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners